Epidemiology of diabetic foot and management of foot problems in India

International Journal of Lower Extremity Wounds

Volumn 9, Issue 3, 2010, Pages 122-126

  Viswanathan, Vijay ^a  

^a MV Hospital for Diabetes   (India)

Author keywords

Diabetic foot; Epidemiology; India

Indexed keywords

ANTIOXIDANT; BACTERICIDE; CATALASE; EPIDERMAL GROWTH FACTOR; GAMMA UROGASTRONE; MATRIX METALLOPROTEINASE; PEROXIDASE; PLACEBO; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; REGEN D; SERINE PROTEINASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CLOSTRIDIUM; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; ENTEROBACTERIACEAE; FOOT AMPUTATION; FUSOBACTERIUM; GANGRENE; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; INFECTION; INSULIN TREATMENT; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATIENT EDUCATION; PEPTOSTREPTOCOCCUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PSEUDOMONAS; SHORT SURVEY; STAPHYLOCOCCUS; STREPTOCOCCUS; WOUND HEALING;

DELIVERY OF HEALTH CARE; DIABETIC FOOT; HUMANS; INDIA; MORBIDITY;

EID: 77955672768     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734610380026     Document Type: Short Survey

References (28)

1. Apelqvist J., Bakker K., van Houtum WH, Schaper NC The development of global consensus guidelines on the management of the diabetic foot. Diabetes Metab Res Rev. 2008 ; 24 (Suppl 1). S116 - S118.
2. Armstrong DG, Lavery LA, Harkless LB Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998 ; 21: 855-859.
3. Clinical Guidelines Task Force. Guide for Guidelines: A Guide for Clinical Guideline Development. Brussels, Belgium: International Diabetes Federation ; 2003.
4. Van Houtum WH Barriers to the delivery of diabetic foot care. Lancet. 2005 ; 366: 1678-1679.
5. International Diabetes Federation. IDF Atlas. 4 th ed. Brussels, Belgium: International Diabetes Federation ; 2009.
6. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 ; 27: 1047-1053.
7. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord. 2004 ; 28 (Suppl 3). S2 - S9.
8. Unwin N. The diabetic foot in the developing world. Diabetes Metab Res Rev. 2008 ; 24 (Suppl 1). S31 - S33.
9. Jeffcoate WJ, Harding KG Diabetic foot ulcers. Lancet. 2003 ; 361: 1545-1551.
10. Boulton AJ, Vileikyte L., Ragnarson-Tennvall G., Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005 ; 366: 1719-1724.
11. Oyibo SO, Jude EB, Tarawneh I., et al. The effect of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 2001 ; 18: 133-138.
12. Apelqvist J., LarssonJ, Agardh CD Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993 ; 233: 485-491.
13. Jeffcoate WJ, Chipchase SY, Ince P., Game FL Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006 ; 29: 1784-1787.
14. Viswanathan V., Thomas N., Tandon N., et al. Profile of diabetic foot complications and its associated complications: a multicentric study from India. J Assoc Physicians India. 2005 ; 53: 933-936.
15. Vijay V., Snehalatha C., Terin M., Ramachandran A. Socio-cultural practices that may affect the development of the diabetic foot. IDF Bull. 1997: 42 ; 10-12.
16. Viswanathan V. The diabetic foot: Perspectives from Chennai, south India. Int J Lower Extrem Wounds. 2007 ; 6: 34-36.
17. Viswanathan V., Sivagami, Rajasekar S. Diabetic foot: An Indian scenario. Asian J Diabetol. 2005 ; 7 (3). 9-11.
18. Viswanathan V., Kumpatla S. ; Indian Diabetic Amputation Study Group. Patterns and causes of amputation in diabetic patients: A multicentre study from India. JAPI (in press).
19. Morbach S., Lutalet JK, Viswanathan V., et.al. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med. 2004 ; 21: 91-95.
20. V. Viswanathan, Jasmine JJ, Snehalatha C., Ramachandran A. Prevalence of pathogens in diabetic foot infection in south Indian type 2 diabetic patients. J Assoc Physicians India. 2002 ; 50: 1013-1016.
21. Viswanathan V., Narasimhan DVL, Seena R., et al. Clinical profile of diabetic foot infection in south India: a retrospective study. Diabet Med. 2000 ; 17: 215-218.
22. Vairamon S., Babu M., Viswanathan V. Oxidative stress markers regulating the healing of diabetic foot ulcers in patients with type 2 diabetes. Wounds. 2009 ; 21: 273-279.
23. Viswanathan V., Kumpatla S., Gnanasundaram S., Gopanakrishna G., Das B. Assessment of ulcer related outcomes in type 2 diabetic patients with foot ulceration in India. J Diabet Foot Complicat. 2009 ; 1. http://jdfceditors. wordpress.com/2009/06/30/assessment-of-ulcer-related-outcomes-in-type-2- diabetic-patients-with-foot-ulceration-in-india/. Accessed July 13, 2010.
24. Viswanathan V., Sivagami M., Seena R., Snehalatha C., Ramachandran A. Amputation prevention initiative in south India: Positive impact of foot care education. Diabetes Care. 2005 ; 28: 1019-1021.
25. Abraham JA, Klagsbrun M. Modulation of wound repair by members of the fibroblast growth factor family. Mol Cell Biol Wound Repair. 1996 ; 2: 195-248.
26. Treating Diabetic Foot: Express Healthcare. http://www. expresshealthcaremgmt.com/200909/knowledge01.shtml. Accessed July 13, 2010.
27. Tsang MW, Wong WK, Hung CS, Lai KM, Tang W., Cheung EYN. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care. 2003 ; 26: 1856-1861.
28. Vijay V., Sharad P., Sekar N., Murthy GSR. A phase III study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN-DTM 150) in healing diabetic foot ulcers. Wounds. 2006 ; 18: 186-196.